Anthropic began trading on the Nasdaq under the ticker ANT on 19 November, following an initial public offering (IPO) that priced shares at $83. While the company set aside 15% of its 980 million Class A shares for retail investors, strict eligibility rules and regional restrictions prevented many from participating at the primary price. Those who could not access the IPO were forced to buy after the market opened, where shares surged 34% to $111.50. The stock subsequently dropped 13% to close at $97.17, with prices falling further toward the $84 level in the following session.
Access to the $83 offering was limited by geography and account requirements. Participating brokers, including Charles Schwab, Fidelity, Robinhood, and E*TRADE, imposed specific conditions. For example, Fidelity required clients to hold at least $25,000 in eligible assets and purchase a minimum of 25 shares. In the UK, Hargreaves Lansdown saw high demand, with 45,811 applications resulting in clients receiving only 33.6% of their requested shares. Investors in regions such as the Czech Republic were largely excluded from the primary offering, forcing them to trade on the secondary market at higher prices.
Data from Vanda Research indicates that retail turnover reached between $700 million and $800 million on the debut day, the highest in the firm's dataset since 2012. However, net buying was only $60 million, suggesting that early investors sold into the opening price spike while others bought in at the peak. Some brokers offered pre-IPO contracts for difference (CFDs), which allowed speculation on the valuation without granting shareholder rights or access to the $83 primary price.